United Therapeutics Corporation Long-Lived Assets
United Therapeutics Corporation (UTHR) had Long-Lived Assets of $1.76 billion as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-02-25
- 2025-12-31: Long-Lived Assets $1.76B.
- 2024-12-31: Long-Lived Assets $1.25B.
- 2023-12-31: Long-Lived Assets $1.07B.
- 2022-12-31: Long-Lived Assets $883.70M.
| Period end | Long-Lived Assets |
|---|---|
| 2025-12-31 | $1.76B 10-K · filed 2026-02-25 |
| 2024-12-31 | $1.25B 10-K · filed 2026-02-25 |
| 2023-12-31 | $1.07B 10-K · filed 2026-02-25 |
| 2022-12-31 | $883.70M 10-K · filed 2025-02-26 |
| 2021-12-31 | $780.90M 10-K · filed 2024-02-21 |
| 2020-12-31 | $731.60M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |